Mark Nah

Director, R&D and Engineering at Response Biomedical Corp. - Vancouver, British Columbia, CA

Mark Nah's Colleagues at Response Biomedical Corp.
Shariq Faheem

Order Management Specialist

Contact Shariq Faheem

Adriana PhD

Senior Manager, Operational Excellence and Special Projects

Contact Adriana PhD

Mariana C.

Sr Quality Assurance Specialist & QMR

Contact Mariana C.

Negar Ziaie

International Sales Manager

Contact Negar Ziaie

Denzil Esow

Biotechnology Manufacturing Laboratory Specialist

Contact Denzil Esow

View All Mark Nah's Colleagues
Mark Nah's Contact Details
HQ
(888) 591-5577
Location
Company
Response Biomedical Corp.
Mark Nah's Company Details
Response Biomedical Corp. logo, Response Biomedical Corp. contact details

Response Biomedical Corp.

Vancouver, British Columbia, CA • 72 Employees
BioTech/Drugs

Response Biomedical Corp. develops, manufactures and markets the RAMP® system, a rapid diagnostics platform that delivers lab quality performance for efficient patient management in acute care settings. RAMP® is a global leader in comprehensive acute care testing with a wide range of markers available including Troponin I, CK-MB, Myoglobin, NT-proBNP, D-dimer and Procalcitonin. For effective and efficient patient care, RAMP® tests aid in the diagnosis of Acute Myocardial Infarction, Heart Failure and Sepsis.

Cardiac Diseases Point Of Care Instruments Ramp West Nile Nt-Probnp Response Biomedical Influenza A & B Test
Details about Response Biomedical Corp.
Frequently Asked Questions about Mark Nah
Mark Nah currently works for Response Biomedical Corp..
Mark Nah's role at Response Biomedical Corp. is Director, R&D and Engineering.
Mark Nah's email address is ***@responsebio.com. To view Mark Nah's full email address, please signup to ConnectPlex.
Mark Nah works in the BioTech/Drugs industry.
Mark Nah's colleagues at Response Biomedical Corp. are Shariq Faheem, Adriana PhD, Mariana C., Ebin Thomas, Negar Ziaie, Andrei Ilie, Denzil Esow and others.
Mark Nah's phone number is (888) 591-5577
See more information about Mark Nah